After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Novavax performed well last year, but the company's shares are down significantly over the past three years and are not far ...

WASHINGTON >> The White House withdrew President Donald Trump’s nomination of former Republican congressman and vaccine ...

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...

As we reflect on five years of COVID-19, it’s clear that the impacts are still unfolding. The life sciences—and we as ...

With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...

Five years ago on Tuesday, the World Health Organization declared COVID-19 a global pandemic, and the impact of the virus and ...

As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...

Novavax (NVAX) has recently seen a decrease in stock value, dropping after announcing Q4 results that missed revenue expectations. The company ...

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.